オプションチェーンは、Cybinの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、Cybinの市場センチメントを評価します。.

Cybin (AMEX:CYBN) 株価情報, オプションチェーン

Cybin

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.

Cybin Inc

Cyber Security 1 AB ADR

WIIM

WEX shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY25 adjusted EPS guidance.

Teladoc Health Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDOC#NYSE">TDOC</a>) reported financial results for the first quarter Wednesday after the bell. Here&#8217;s a rundown<a href="https://www.benzinga.com/pressreleases/25/04/g45116556/teladoc-health-reports-first-quarter-2025-results"> of the report</a>.
Q1 Earnings: Teladoc reported first-quarter revenue of $629.4 million, beating the <a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">consensus estimate</a>&nbsp;of $619.29 million, according to <a href="https://benzinga.grsm.io/gxjhpowx7zks" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>. The company reported a first-quarter loss of 53 cents per share, missing analyst estimates for a loss of 34 cents per share.
Total revenue was down 3% on a year-over-year basis. Revenue fell 4% year-over-year in the U.S., but International revenue grew 6% year-over-year. Here&#8217;s a breakdown of revenue by segment:
<ul>
<li>Integrated Care revenue: up 3% to $389.5 million</li>
</ul>
<ul>
<li>BetterHelp&nbsp;revenue: down 11% to $239.9 million</li>
</ul>
<ul>
<li>Access Fees revenue: down 6% to $525.7 million</li>
</ul>
<ul>
<li>Other revenue: up 16% to $103.6 million</li>
</ul>
Cash flow from operations totaled $15.9 million in the quarter. The company said capital expenditures and capitalized software development costs came in at&nbsp;$31.6 million. Teladoc ended the period with approximately $1.19 billion in cash and cash equivalents.
&#8220;We are pleased with the solid start to 2025. Consolidated revenue and adjusted EBITDA were towards the higher end of our&nbsp;first quarter&nbsp;guidance&nbsp;ranges, including our Integrated Care segment being above our ranges for both measures and BetterHelp segment results in the upper half of our ranges as well,&#8221; said&nbsp;Chuck Divita, CEO of Teladoc Health.
&#8220;We also continue to make progress towards strategic priorities aimed at driving sustainable performance, including advancing our position in virtual mental health.&#8221;
In connection with the earnings release, Teladoc also announced that it acquired virtual mental health therapy provider UpLift for $30 million in an <a href="https://www.benzinga.com/pressreleases/25/04/g45116095/teladoc-health-acquires-uplift-expanding-consumer-access-to-mental-health-care-services-through-co">all-cash transaction</a>. The deal also includes up to $15 million in additional contingent earnout consideration.
Guidance:&nbsp;Teladoc expects second-quarter revenue of $614 million to $633 million, and full-year revenue of $2.47 billion to $2.58 billion. Analysts are anticipating full-year revenue of $2.52 billion, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
The company also lowered its full-year earnings outlook. Teladoc anticipates a 2025 loss of 90 cents to $1.40 per share, down from prior guidance for a loss of 50 cents to $1.10 per share. Analysts are forecasting a loss of 93 cents per share. 
Teladoc executives are currently discussing the quarter on a call with investors and analysts that got started at 4:30 p.m. ET
TDOC Price Action: <a href="https://www.benzinga.com/quote/TDOC" target="_blank" rel="noreferrer noopener">Teladoc shares</a> were down 5.42% in after-hours, trading at $6.80 at the time of publication on Wednesday, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/45115442/sell-in-may-and-go-away-looks-outdated-as-mayjuly-data-signal-bullish-sp-500-seasonality">&#8216;Sell In May And Go Away&#8217; Looks Outdated As May–July Data Signal Bullish S&amp;P 500 Seasonality</a></li>
</ul>
Photo: courtesy of Teladoc Health.

Earnings

News

Guidance

Health Care

After-Hours Center

Movers

TDOC

Teladoc Health Stock Slides On Q1 Earnings As Company Cuts FY25 Guidance

National Fuel Gas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NFG#NYSE">NFG</a>) raises FY2025 Adj EPS guidance from $6.50-$7.00 to $6.75-$7.05 vs $7.00 analyst estimate..

National Fuel Gas Raises FY2025 Adj EPS Guidance from $6.50-$7.00 to $6.75-$7.05 vs $7.00 Est

GFL Environmental shares are trading lower after the company reported worse-than-expected Q1 EPS results.

Office Props IT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPI#NASDAQ">OPI</a>) reported quarterly earnings of $0.06 per share which missed the analyst consensus estimate of $0.30 by 80 percent. This is a 92.41 percent decrease over earnings of $0.79 per share from the same period last year. The company reported $107.10 million in sales this quarter. This is a 23.19 percent decrease over sales of $139.44 million the same period last year.

Earnings Misses

Office Props IT Q1 FFO $0.06 Misses $0.30 Estimate, Sales $107.10M Down From $139.44M YoY

MVB Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVBF#NASDAQ">MVBF</a>) reported quarterly earnings of $0.27 per share which beat the analyst consensus estimate of $0.25 by 8 percent. This is a 20.59 percent decrease over earnings of $0.34 per share from the same period last year. The company reported quarterly sales of $33.68 million which missed the analyst consensus estimate of $34.48 million by 2.32 percent. This is a 11.29 percent decrease over sales of $37.97 million the same period last year.

Earnings Beats

MVBF

MVB Financial Q1 EPS $0.27 Beats $0.25 Estimate, Sales $33.68M Miss $34.48M Estimate

National Fuel Gas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NFG#NYSE">NFG</a>) reported quarterly earnings of $2.39 per share which beat the analyst consensus estimate of $2.20 by 8.64 percent. This is a 33.52 percent increase over earnings of $1.79 per share from the same period last year. The company reported quarterly sales of $729.95 million which missed the analyst consensus estimate of $779.37 million by 6.34 percent. This is a 15.88 percent increase over sales of $629.94 million the same period last year.

National Fuel Gas Q2 Adj. EPS $2.39 Beats $2.20 Estimate, Sales $729.95M Miss $779.37M Estimate

Pilgrim's Pride shares are trading lower after the company reported worse-than-expected Q1 financial results.

NCSM

NCS Multistage Holdings CEO Ryan Hummer Says "We Have Not Experienced A Significant Impact On Our Business From Escalating Global Trade Tensions, And We Expect That To Continue To Be The Case In The Second Quarter Of 2025."

ATNI

ATN Says FY25 Revenue Excluding Construction Revenue Is Expected To Be In Line With Last Year's Result Of $725M

Contango ORE, Inc. ("Contango" or the "Company") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTGO#NYSE">CTGO</a>) announces that Contango is in Washington DC this week for the annual 'Alaska On The Hill' event. The Company is joined by 120 of its fellow Alaskans from across the various businesses to bring Alaska's unique business voice to the Nation's Capital to advocate for a healthy Alaskan economy and a secure future for Alaska.
Rick Van Nieuwenhuyse, the Company's President and CEO stated, "We are excited to be here in Washington DC to meet with our representatives and other delegates to tell them about the mining industry in general and about production at our Manh Choh gold mine as well as the progress we are making on our two development stage projects - Lucky Shot and Johnson Tract. Johnson Tract specifically is getting a lot of attention from the Trump administration because of our plans to produce 4 critical metals - gold, silver, copper and zinc. Alaska is front and center for the Trump Administration and it's promising to see the federal government fully supporting mining and unleashing Alaska's extraordinary resource potential. We are happy to report that we remain on track to produce 60,000 ounces of gold from Manh Choh this year with our second campaign of 2025 starting in mid-May. Additionally, we expect to have our Johnson Tract PEA out next week and our Q1-2025 financials released shortly thereafter. It is a very exciting time for mining in Alaska, especially for Contango Ore."

CTGO

Contango Provides Corporate Update Including The Company Being On Track To Produce 60,000 Ounces Of Gold From Manh Choh This Year

FTAI

FTAI Aviation shares are trading lower after the company reported worse-than-expected Q1 financial results.

GFL Environmental (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GFL#NYSE">GFL</a>)&nbsp;

GFL Environmental says, "The strength of our first quarter results reinforces our confidence in achieving our full year guidance."

ATN International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATNI#NASDAQ">ATNI</a>) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.18) by 283.33 percent. This is a 64.29 percent decrease over losses of $(0.42) per share from the same period last year. The company reported quarterly sales of $179.30 million which beat the analyst consensus estimate of $178.67 million by 0.35 percent. This is a 4.01 percent decrease over sales of $186.79 million the same period last year.

ATN International Q1 EPS $(0.69) Misses $(0.18) Estimate, Sales $179.30M Beat $178.67M Estimate

NCS Multistage Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCSM#NASDAQ">NCSM</a>) reported quarterly earnings of $1.51 per share which beat the analyst consensus estimate of $0.64 by 135.94 percent. This is a 84.15 percent increase over earnings of $0.82 per share from the same period last year. The company reported quarterly sales of $50.01 million which beat the analyst consensus estimate of $44.69 million by 11.89 percent. This is a 14.02 percent increase over sales of $43.86 million the same period last year.

NCS Multistage Holdings Q1 EPS $1.51 Beats $0.64 Estimate, Sales $50.01M Beat $44.69M Estimate

Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) has outperformed the market over the past 15 years by 7.3% on an annualized basis producing an average annual return of 18.49%. Currently, Alphabet has a market capitalization of $1.94 trillion. 
Buying $1000 In GOOGL: If an investor had bought $1000 of GOOGL stock 15 years ago, it would be worth $12,470.65 today based on a price of $160.00 for GOOGL at the time of writing.
<h3>Alphabet's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746045912_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

GOOGL

If You Invested $1000 In This Stock 15 Years Ago, You Would Have This Much Today

WGRX

Wellgistics Health Reports Q1 Highlights, Reports 354 New Independent Pharmacies Added

Radian Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDN#NYSE">RDN</a>) reported quarterly earnings of $0.99 per share which beat the analyst consensus estimate of $0.96 by 3.13 percent. This is a 1 percent decrease over earnings of $1.00 per share from the same period last year. The company reported quarterly sales of $236.68 million which missed the analyst consensus estimate of $242.70 million by 2.48 percent. This is a 0.35 percent increase over sales of $235.86 million the same period last year.

Radian Group Q1 Adj. EPS $0.99 Beats $0.96 Estimate, Sales $236.68M Miss $242.70M Estimate

Aflac shares are trading lower after the company reported worse-than-expected Q1 financial results.

CSX Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSX#NASDAQ">CSX</a>) today announced that it has secured the ratification of new five-year collective bargaining agreements with the Brotherhood of Railroad Signalmen (BRS) and the International Brotherhood of Boilermakers, Iron Ship Builders, Forgers &amp; Helpers (IBB).

CSX Corp. Secures Ratification Of 5-yr Collective Bargaining Agreements With Brotherhood Of Railroad Signalmen And IBB

Press Releases

Cybin to Present 12-Month Phase 2 Data for CYB003 in Major Depressive Disorder on November 18, 2024

Cybin Reports Positive Phase 2 Data for CYB003, Demonstrating Breakthrough 12-Month Efficacy in Treating Major Depressive Disorder

Cybin to Participate in Water Tower Research Fireside Chat on December 11, 2024

Cybin Announces Poster Presentations at the 2024 American College of Neuropsychopharmacology Annual Meeting, Including CYB003 12-Month Efficacy Results

Cybin to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

Cybin Highlights 2024 Accomplishments and Upcoming Milestones for 2025

Cybin Launches Strategic Clinical Site Partnerships to Support PARADIGM, a Multinational Pivotal Phase 3 Program Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder

Comments

Cybin

Cybin (CYBN) オプション

Cybin (AMEX:CYBN) 株価情報, オプションチェーン

ニュース

パートナーシップ

ベンジンガ・グローバル